Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1260139-70-5
1353011-95-6
2101206-30-6
2101206-92-0
1214319-94-4
1283658-79-6
1357923-30-8 | Benzyl 4-(2-methoxy-2-oxoethyl)piperazine-1-carboxylate | AA00HUBL | MFCD23378648
1367368-40-8 | 4-Methyl-n'-[(1e)-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methylidene]benzene-1-sulfonohydrazide | AA00HULV | MFCD28127160
13788-94-8 | 3,5-Dimethyl-1-(4-nitrophenyl)pyrazole | AA00HV0O | MFCD00187810
1391733-00-8 | 4-(Hydrazinylmethyl)-1-methyl-1h-pyrazole trihydrochloride | AA00HVCQ | MFCD23378503
14025-15-1 | Copper disodium edta | AA00HVPS | MFCD00072540
1417301-54-2 | [4-Methanesulfonyl-3-(trifluoromethyl)phenyl]boronic acid | AA00HW3P | MFCD27935820
142469-14-5 | Benzenesulfonamide,N-[[[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]amino]carbonyl]-2-(trifluoromethyl)- | AA00HWF8 | MFCD06798291
1431364-00-9 | Cis-tert-butyl 3-(4-methoxyphenyl)aziridine-2-carboxylate | AA00HWQD | MFCD24368287
1443978-99-1 | 6-Methyl-4-oxo-4,5-dihydro[1,2,3]triazolo[1,5-a]pyrazine-3-carboxylic acid | AA00HWZV | MFCD25953213
1449133-12-3 | 3-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-propyn-1-ol | AA00HX76 | MFCD16294528
